Back to Search
Start Over
Research in the Area of Ankylosing Spondylitis Reported from Sun Yat-sen University (A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone...).
- Source :
- Drug Week; 6/16/2023, p2058-2058, 1p
- Publication Year :
- 2023
-
Abstract
- According to news originating from Sun Yat-sen University by NewsRx correspondents, research stated, "Ankylosing spondylitis (AS) is a common rheumatic disorder distinguished by chronic inflammation and heterotopic ossification at local entheses sites." Keywords: Ankylosing Spondylitis; Bone Diseases and Conditions; Bone Research; Health and Medicine; Heterotopic Ossification; Infectious Bone Diseases and Conditions; Inflammation; Musculoskeletal Diseases and Conditions; Rheumatology; Spinal Diseases and Conditions; Spondylitis EN Ankylosing Spondylitis Bone Diseases and Conditions Bone Research Health and Medicine Heterotopic Ossification Infectious Bone Diseases and Conditions Inflammation Musculoskeletal Diseases and Conditions Rheumatology Spinal Diseases and Conditions Spondylitis 2058 2058 1 06/12/23 20230616 NES 230616 2023 JUN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on ankylosing spondylitis have been published. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 15316440
- Database :
- Complementary Index
- Journal :
- Drug Week
- Publication Type :
- Periodical
- Accession number :
- 164186942